Ledger.Open graph →
SEC Form D · filed March 15, 2016

NORTHWEST BIOTHERAPEUTICS INC

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BETHESDA, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Navid F. Malik · Bethesda, MDDirectorAlton L. Boynton · Bethesda, MDExec · DirectorLinda F. Powers · Bethesda, MDExec · DirectorJerry A. Jasinowski · Bethesda, MDDirectorRobert A. Farmer · Bethesda, MDDirectorCofer L. Black · Bethesda, MDDirectorSusan L. Bayh · Bethesda, MDDirectorCofer L. Black · Bethesda, MDDirectorNavid F. Malik · Bethesda, MDDirectorAlton L. Boynton · Bethesda, MDExec · DirectorSusan L. Bayh · Bethesda, MDDirectorLinda F. Powers · Salt Lake City, UTExec · DirectorJerry A. Jasinowski · Bethesda, MDDirectorRobert A. Farmer · Bethesda, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗